TABLEĀ 2

MiSH and SCORAD of the 18 AD patients in the BCP2 and B7U treatment groups, both prior to treatment and posttreatment

Sample IDTypeMiSH at:SCORAD at:
BaselineAfter treatmentBaselineAfter treatment
1039I0.0617.6433.406.62
1069I0.1419.8855.8036.50
1072I0.1025.0633.5710.65
1052I0.2225.8435.1222.82
1050I2.6030.6273.0033.50
1001I2.4846.0841.8316.52
1024I0.0245.0642.9147.24
1056II30.5412.6648.8141.48
1080II60.6259.4228.3010.35
1089II34.2035.8828.8820.31
1005II26.9030.8465.7525.29
1070II41.5862.1413.201.95
1030II38.6859.6046.3944.14
1060II35.0459.4644.8220.62
1064II15.3841.0438.557.79
1077II30.1665.8431.2019.94
1078II20.9060.9242.2413.31